Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L A Jaber

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Annals of Pharmacotherapy|February 1, 1996
Metformin: an antihyperglycemic agent for treatment of type II diabetesW R Melchior, L A Jaber
The Annals of Pharmacotherapy|July 1, 1995
Peripheral diabetic neuropathy: current concepts in treatmentP T Calissi, L A Jaber
The Annals of Pharmacotherapy|June 1, 1995
Diabetes and related metabolic risk factors among Arab AmericansL A Jaber, R L Slaughter, G Grunberger
The Annals of Pharmacotherapy|March 1, 1993
Angiotensin-converting enzyme inhibitors in diabetic nephropathyW R Melchior, V Bindlish, L A Jaber
Journal of the American Academy of Dermatology|July 1, 1986
Oral methoxsalen photochemotherapy of extensive pityriasis alba. Preliminary reportS Zaynoun, L A Jaber, A K Kurban
Therapeutic Drug Monitoring|February 1, 1996
The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitusL A Jaber, M P Ducharme, H Halapy
The Annals of Pharmacotherapy|May 1, 1996
Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin-dependent diabetes mellitusL A Jaber, E J Antal, I R Welshman
The Annals of Pharmacotherapy|July 1, 1992
Possible correlation between glycemia and blood pressure in black, diabetic, hypertensive patientsL A Jaber, W R Melchior, D R Rutledge
Clinical Pharmacy|February 1, 1989
Enoxacin: a new fluoroquinoloneL A Jaber, E M Bailey, M J Rybak
Journal of Clinical Pharmacology|February 1, 1990
An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizideL A Jaber, N J Wenzloff, P Komanicky, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Annals of Pharmacotherapy|February 1, 1996
Metformin: an antihyperglycemic agent for treatment of type II diabetesW R Melchior, L A Jaber
The Annals of Pharmacotherapy|July 1, 1995
Peripheral diabetic neuropathy: current concepts in treatmentP T Calissi, L A Jaber
The Annals of Pharmacotherapy|June 1, 1995
Diabetes and related metabolic risk factors among Arab AmericansL A Jaber, R L Slaughter, G Grunberger
The Annals of Pharmacotherapy|March 1, 1993
Angiotensin-converting enzyme inhibitors in diabetic nephropathyW R Melchior, V Bindlish, L A Jaber
Journal of the American Academy of Dermatology|July 1, 1986
Oral methoxsalen photochemotherapy of extensive pityriasis alba. Preliminary reportS Zaynoun, L A Jaber, A K Kurban
Therapeutic Drug Monitoring|February 1, 1996
The effects of obesity on the pharmacokinetics and pharmacodynamics of glipizide in patients with non-insulin-dependent diabetes mellitusL A Jaber, M P Ducharme, H Halapy
The Annals of Pharmacotherapy|May 1, 1996
Pharmacokinetics and pharmacodynamics of glyburide in young and elderly patients with non-insulin-dependent diabetes mellitusL A Jaber, E J Antal, I R Welshman
The Annals of Pharmacotherapy|July 1, 1992
Possible correlation between glycemia and blood pressure in black, diabetic, hypertensive patientsL A Jaber, W R Melchior, D R Rutledge
Clinical Pharmacy|February 1, 1989
Enoxacin: a new fluoroquinoloneL A Jaber, E M Bailey, M J Rybak
Journal of Clinical Pharmacology|February 1, 1990
An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizideL A Jaber, N J Wenzloff, P Komanicky, et al.
Pageof 2